[1]王國琛,劉江彥.廣濟柴胡方治療成人社區獲得性肺炎的療效[J].醫學信息,2020,(04):168-170.[doi:10.3969/j.issn.1006-1959.2020.04.056]
 WANG Guo-chen,LIU Jiang-yan.Effect of GuangJi ChaiHu Fang in the Treatment of Adult Community Acquired Pneumonia[J].Medical Information,2020,(04):168-170.[doi:10.3969/j.issn.1006-1959.2020.04.056]
點擊復制

廣濟柴胡方治療成人社區獲得性肺炎的療效()
分享到:

醫學信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期數:
2020年04期
頁碼:
168-170
欄目:
中醫中藥
出版日期:
2020-02-15

文章信息/Info

Title:
Effect of GuangJi ChaiHu Fang in the Treatment of Adult Community Acquired Pneumonia
文章編號:
1006-1959(2020)04-0168-03
作者:
王國琛劉江彥
(天津市東麗區中醫醫院內一科,天津 300300)
Author(s):
WANG Guo-chenLIU Jiang-yan
(Department of Internal Medicine,Subject One,Dongli District Traditional Chinese Medicine Hospital,Tianjin 300300,China)
關鍵詞:
社區獲得性肺炎廣濟柴胡方中醫癥狀
Keywords:
Community-acquired pneumoniaGuangji Chaihu FangSymptoms of traditional Chinese medicine
分類號:
R563.1
DOI:
10.3969/j.issn.1006-1959.2020.04.056
文獻標志碼:
A
摘要:
目的 探討廣濟柴胡方治療成人社區獲得性肺炎(CAP)的療效。方法 收集2016年5月~2017年4月我科收治的CAP患者112例,按照隨機數字表法分為治療組(55例)和對照組(57例)。對照組給予常規西醫治療,治療組在對照組基礎上給予廣濟柴胡方治療,比較兩組臨床療效、治療前后中醫證候積分、實驗室指標及不良反應發生情況。結果 治療組總有效率為92.27%,高于對照組的84.21%,差異有統計學意義(P<0.05)。治療后,治療組咳嗽咯痰、舌象、脈象、總分均低于對照組,差異有統計學意義(P<0.05);治療組白細胞計數(WBC)、中性粒細胞百分比(NE%)、C反應蛋白(CRP)低于對照組,差異有統計學意義(P<0.05)。兩組不良反應發生率比較,差異無統計學意義(P>0.05)。結論 廣濟柴胡方治療CAP療效確切,可改善肺炎患者臨床癥狀,降低白細胞、CRP等炎性因子水平,安全有效。
Abstract:
Objective To explore the efficacy of Guangji Chaihu Fang in the treatment of adult community acquired pneumonia (CAP).Methods A total of 112 patients with CAP treated in our department from May 2016 to April 2017 were collected and according to the random number table method, they were divided into treatment group (55 cases) and control group (57 cases). The control group was given conventional western medicine treatment, and the treatment group was given Guangji Chaihu Fang on the basis of the control group. Comparing the clinical efficacy, TCM syndrome scores, laboratory indicators [leukocyte count (WBC), neutrophil percentage (NE%), C-reactive protein (CRP)], and adverse reactions of the two groups.Results The total effective rate in the treatment group was 92.27%, which was higher than 84.21% in the control group,the difference was statistically significant(P<0.05). After treatment, the cough, expectoration, tongue, pulse and total scores in the treatment group were lower than those in the control group,the differences were statistically significant(P<0.05); WBC, NE%, and CRP were lower in the treatment group than in the control group,the differences were statistically significant(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion Guangji Chaihu Fang is effective in treating CAP. It can improve the clinical symptoms of patients with pneumonia and reduce inflammatory factors such as white blood cells and CRP. It is safe and effective.

參考文獻/References:

[1]中華醫學會,中華醫學會雜志社,中華醫學會全科醫學分會,等.成人社區獲得性肺炎基層診療指南(實踐版2018)[J].中華全科醫師雜志,2016,18(2):127-133. [2]中華中醫藥學會內科分會,中華中醫藥學會肺系病分會,中國民族醫藥學會肺病分會.社區獲得性肺炎中醫診療指南(2018修訂版)[J].中醫雜志,2019,60(4):350-360 [3]鄭筱萸.中藥新藥臨床研究指導原則(試行)[M].北京:中國醫藥科技出版社,2002:356-361. [4]李建生.基于療效優勢的中醫治療社區獲得性肺炎切入點的思考[J].中醫學報,2017,32(3):345-347. [5]尹鑫,邙光偉,項福星,等.柴胡皂苷及黃酮類化合物藥理作用研究[J].園藝與種苗,2018(7):29-31. [6]雷載權.中藥學[M].上海:上?萍汲霭嫔,2002 [7]代曉光,宋琳.五味子現代藥理作用及臨床應用研究進展[J].中醫藥信息,2017,34(5):121-123. [8]李慶耀,梁生林.陳皮的藥用研究進展[J].中成藥,2008,30(2):247. [9]時登龍,劉代緩,曹喆,等.苦杏仁藥理作用及炮制工藝研究進展[J].亞太傳統醫藥,2018,14(12):106-107. [10]王茅,徐祉君,鄭文博.甘草的臨床運用淺析[J].光明中醫,2017,32(11):1669-1671. [11]李明珠.中西醫結合治療社區獲得性肺炎54例臨床觀察[J].中國民族民間醫藥,2016,25(10):59-60.

相似文獻/References:

[1]趙建美,邵 巖.血必凈治療社區獲得性肺炎的研究進展[J].醫學信息,2018,(02):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
 ZHAO Jian-mei,SHAO Yan.Research Progress of Xuebijing in Treating Community Acquired Pneumonia[J].Medical Information,2018,(04):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
[2]包克珍,許云麗.新生兒社區獲得性肺炎的臨床特征分析[J].醫學信息,2018,(02):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
 BAO Ke-zhen,XU Yun-li.Clinical Characteristics of Neonatal Community Acquired Pneumonia[J].Medical Information,2018,(04):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
[3]趙建美,邵 巖,李京津.電腦中頻藥透對治療老年社區獲得性肺炎的療效分析[J].醫學信息,2018,(03):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
 ZHAO Jian-mei,SHAO Yan,LI Jing-jin.Analysis of the Efficacy of Computer Medium Frequency Drug Penetration in the Treatment of Elderly Community-acquired Pneumonia[J].Medical Information,2018,(04):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
[4]曹立杰,楊林瀛,于國云,等.N-末端腦鈉肽前體與社區獲得性肺炎患者嚴重程度關系研究[J].醫學信息,2018,(04):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
 CAO Li-jie,YANG Lin-ying,YU Guo-yun,et al.Study on the Relationship between N-terminal Brain Natriuretic Peptide Precursors and the Severity of Community-acquired Pneumonia[J].Medical Information,2018,(04):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
[5]武珊珊.喜炎平注射液治療社區獲得性肺炎臨床療效的Meta分析[J].醫學信息,2018,(14):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
 WU Shan-shan.Meta-analysis of Clinical Efficacy of Xiyanping Injection in the Treatment of Community-acquired Pneumonia[J].Medical Information,2018,(04):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
[6]徐安林,劉 忠.不同配比的哌拉西林-他唑巴坦治療 老年性社區獲得性肺炎的療效對比[J].醫學信息,2018,(15):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
 XU An-lin,LIU Zhong.Comparison of the Efficacy of Different Ratios of Piperacillin-tazobactam in Elderly Community Acquired Pneumoni[J].Medical Information,2018,(04):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
[7]許 俊.慢性阻塞性肺疾病急性加重期與慢性阻塞性肺疾病并發社區獲得性肺炎患者的臨床對比[J].醫學信息,2018,(22):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
 XU Jun.Clinical Comparison of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Complicated with Community Acquired Pneumonia[J].Medical Information,2018,(04):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
[8]遠 穎.成人社區獲得性肺炎中醫藥研究[J].醫學信息,2018,(23):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]
 YUAN Ying.Traditional Chinese Medicine Research on Adult Community Acquired Pneumonia[J].Medical Information,2018,(04):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]
[9]陳亞南,陳 賽,毛琦善.青壯年與中老年社區獲得性肺炎病原體的對比分析[J].醫學信息,2019,(01):145.[doi:10.3969/j.issn.1006-1959.2019.01.045]
 CHEN Ya-nan,CHEN Sai,MAO Qi-shan.Comparative Analysis of Pathogens of Acquired Pneumonia among Young Adults and Middle-aged and Elderly People[J].Medical Information,2019,(04):145.[doi:10.3969/j.issn.1006-1959.2019.01.045]
[10]林振濤.重癥社區獲得性肺炎的診治[J].醫學信息,2019,(22):43.[doi:10.3969/j.issn.1006-1959.2019.22.014]
 LIN Zhen-tao.Diagnosis and Treatment of Severe Community Acquired Pneumonia[J].Medical Information,2019,(04):43.[doi:10.3969/j.issn.1006-1959.2019.22.014]

更新日期/Last Update: 2020-02-15
中国足彩网竞彩 体彩3排5开奖结果 上海 期货 配资公司 阿里巴巴股票行情走势 广东快乐10分彩票 四维图新股票行情牛叉 北京十一选五基本走 5式直缆能赢百家乐吗 黑龙江22选5最新开奖结果 12博百家乐 股票配资平台无法出金